nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—HTR2C—endogenous depression	0.381	0.415	CbGaD
Reboxetine—SLC6A4—endogenous depression	0.316	0.344	CbGaD
Reboxetine—CYP2D6—endogenous depression	0.222	0.242	CbGaD
Reboxetine—SLC6A2—locus ceruleus—endogenous depression	0.00989	0.199	CbGeAlD
Reboxetine—SLC6A2—sympathetic nervous system—endogenous depression	0.00782	0.157	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—endogenous depression	0.00525	0.106	CbGeAlD
Reboxetine—SLC6A4—Serotonin Transporter Activity—TPH2—endogenous depression	0.00292	0.101	CbGpPWpGaD
Reboxetine—SLC6A4—Serotonin Transporter Activity—MAOA—endogenous depression	0.00176	0.0605	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR1A—endogenous depression	0.00156	0.0538	CbGpPWpGaD
Reboxetine—HTR2C—brainstem—endogenous depression	0.00152	0.0306	CbGeAlD
Reboxetine—HTR2C—forebrain—endogenous depression	0.00147	0.0296	CbGeAlD
Reboxetine—SLC6A4—brainstem—endogenous depression	0.00144	0.029	CbGeAlD
Reboxetine—SLC6A4—forebrain—endogenous depression	0.00139	0.028	CbGeAlD
Reboxetine—HTR2C—Serotonin receptors—HTR7—endogenous depression	0.00132	0.0455	CbGpPWpGaD
Reboxetine—SLC6A2—brainstem—endogenous depression	0.00127	0.0256	CbGeAlD
Reboxetine—SLC6A4—Monoamine Transport—TPH2—endogenous depression	0.00124	0.0428	CbGpPWpGaD
Reboxetine—SLC6A2—forebrain—endogenous depression	0.00122	0.0247	CbGeAlD
Reboxetine—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.00119	0.0409	CbGpPWpGaD
Reboxetine—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00114	0.0393	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—TPH2—endogenous depression	0.00107	0.0368	CbGpPWpGaD
Reboxetine—HTR2C—midbrain—endogenous depression	0.000969	0.0195	CbGeAlD
Reboxetine—HTR2C—Serotonin receptors—HTR2A—endogenous depression	0.000925	0.0319	CbGpPWpGaD
Reboxetine—SLC6A4—midbrain—endogenous depression	0.000918	0.0185	CbGeAlD
Reboxetine—SLC6A2—Monoamine Transport—SLC6A4—endogenous depression	0.000854	0.0294	CbGpPWpGaD
Reboxetine—SLC6A2—adrenal gland—endogenous depression	0.000819	0.0165	CbGeAlD
Reboxetine—SLC6A4—endocrine gland—endogenous depression	0.000807	0.0162	CbGeAlD
Reboxetine—HTR2C—nervous system—endogenous depression	0.000797	0.016	CbGeAlD
Reboxetine—HTR2C—central nervous system—endogenous depression	0.000767	0.0154	CbGeAlD
Reboxetine—SLC6A4—nervous system—endogenous depression	0.000755	0.0152	CbGeAlD
Reboxetine—Atomoxetine—HTR2C—endogenous depression	0.000729	0.226	CrCbGaD
Reboxetine—SLC6A4—central nervous system—endogenous depression	0.000727	0.0146	CbGeAlD
Reboxetine—SLC6A2—endocrine gland—endogenous depression	0.00071	0.0143	CbGeAlD
Reboxetine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.000702	0.0242	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR1A—endogenous depression	0.000695	0.024	CbGpPWpGaD
Reboxetine—CYP2D6—brainstem—endogenous depression	0.000695	0.014	CbGeAlD
Reboxetine—CYP2D6—forebrain—endogenous depression	0.00067	0.0135	CbGeAlD
Reboxetine—Benzatropine—CYP2D6—endogenous depression	0.000667	0.206	CrCbGaD
Reboxetine—SLC6A2—nervous system—endogenous depression	0.000665	0.0134	CbGeAlD
Reboxetine—SLC6A2—central nervous system—endogenous depression	0.00064	0.0129	CbGeAlD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—endogenous depression	0.000615	0.0212	CbGpPWpGaD
Reboxetine—HTR2C—brain—endogenous depression	0.000609	0.0123	CbGeAlD
Reboxetine—Atomoxetine—SLC6A4—endogenous depression	0.000604	0.187	CrCbGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR7—endogenous depression	0.000588	0.0203	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000584	0.0201	CbGpPWpGaD
Reboxetine—SLC6A4—brain—endogenous depression	0.000577	0.0116	CbGeAlD
Reboxetine—SLC6A2—brain—endogenous depression	0.000508	0.0102	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR7—endogenous depression	0.000494	0.017	CbGpPWpGaD
Reboxetine—ABCB1—forebrain—endogenous depression	0.000482	0.00971	CbGeAlD
Reboxetine—Atomoxetine—HTR2A—endogenous depression	0.000464	0.144	CrCbGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000461	0.0159	CbGpPWpGaD
Reboxetine—ABCB1—adrenal cortex—endogenous depression	0.000447	0.009	CbGeAlD
Reboxetine—Atomoxetine—CYP2D6—endogenous depression	0.000425	0.131	CrCbGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—endogenous depression	0.000412	0.0142	CbGpPWpGaD
Reboxetine—ABCB1—cardiovascular system—endogenous depression	0.000408	0.00821	CbGeAlD
Reboxetine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.000403	0.0139	CbGpPWpGaD
Reboxetine—CYP3A4—endocrine gland—endogenous depression	0.000395	0.00796	CbGeAlD
Reboxetine—CYP2D6—endocrine gland—endogenous depression	0.000389	0.00783	CbGeAlD
Reboxetine—SLC6A4—Circadian rythm related genes—TPH1—endogenous depression	0.000377	0.013	CbGpPWpGaD
Reboxetine—CYP3A4—nervous system—endogenous depression	0.00037	0.00745	CbGeAlD
Reboxetine—CYP2D6—nervous system—endogenous depression	0.000364	0.00733	CbGeAlD
Reboxetine—ABCB1—pituitary gland—endogenous depression	0.000361	0.00727	CbGeAlD
Reboxetine—CYP3A4—central nervous system—endogenous depression	0.000356	0.00717	CbGeAlD
Reboxetine—CYP2D6—central nervous system—endogenous depression	0.00035	0.00706	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00035	0.012	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000346	0.0119	CbGpPWpGaD
Reboxetine—Diphenhydramine—CYP2D6—endogenous depression	0.000343	0.106	CrCbGaD
Reboxetine—CYP2D6—cerebellum—endogenous depression	0.000343	0.0069	CbGeAlD
Reboxetine—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.000337	0.0116	CbGpPWpGaD
Reboxetine—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000324	0.0112	CbGpPWpGaD
Reboxetine—ABCB1—adrenal gland—endogenous depression	0.000323	0.0065	CbGeAlD
Reboxetine—ABCB1—midbrain—endogenous depression	0.000318	0.00642	CbGeAlD
Reboxetine—ABCB1—thyroid gland—endogenous depression	0.000311	0.00627	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000289	0.00997	CbGpPWpGaD
Reboxetine—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000288	0.00994	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000286	0.00985	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—TPH2—endogenous depression	0.000285	0.00984	CbGpPWpGaD
Reboxetine—ABCB1—endocrine gland—endogenous depression	0.00028	0.00563	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00028	0.00963	CbGpPWpGaD
Reboxetine—CYP2D6—brain—endogenous depression	0.000278	0.0056	CbGeAlD
Reboxetine—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.000278	0.00958	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00027	0.00932	CbGpPWpGaD
Reboxetine—ABCB1—nervous system—endogenous depression	0.000262	0.00527	CbGeAlD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A4—endogenous depression	0.000253	0.00873	CbGpPWpGaD
Reboxetine—ABCB1—central nervous system—endogenous depression	0.000252	0.00508	CbGeAlD
Reboxetine—ABCB1—cerebellum—endogenous depression	0.000246	0.00496	CbGeAlD
Reboxetine—SLC6A4—Circadian rythm related genes—CRH—endogenous depression	0.000245	0.00846	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00021	0.00725	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000203	0.00699	CbGpPWpGaD
Reboxetine—ABCB1—brain—endogenous depression	0.0002	0.00403	CbGeAlD
Reboxetine—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.0002	0.00689	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000194	0.00668	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—OXT—endogenous depression	0.00018	0.00621	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000179	0.00618	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000171	0.00591	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000161	0.00556	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00014	0.00483	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000138	0.00476	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000134	0.00462	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000131	0.0045	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000126	0.00436	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000119	0.00411	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000115	0.00396	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000114	0.00391	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000113	0.00391	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—ADM—endogenous depression	0.000108	0.00374	CbGpPWpGaD
Reboxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000105	0.00362	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—endogenous depression	0.000103	0.00354	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	9.72e-05	0.00335	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	9.19e-05	0.00317	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—OXT—endogenous depression	9.09e-05	0.00313	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CRH—endogenous depression	9.09e-05	0.00313	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR1A—endogenous depression	8.75e-05	0.00302	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	8.54e-05	0.00294	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	8.51e-05	0.00293	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.95e-05	0.00274	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR7—endogenous depression	7.4e-05	0.00255	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—COMT—endogenous depression	6.99e-05	0.00241	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOA—endogenous depression	6.94e-05	0.00239	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	6.89e-05	0.00238	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	6.86e-05	0.00236	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.81e-05	0.00235	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	6.54e-05	0.00225	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADM—endogenous depression	6.13e-05	0.00211	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	6.03e-05	0.00208	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	5.95e-05	0.00205	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADM—endogenous depression	5.57e-05	0.00192	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	5.56e-05	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.44e-05	0.00187	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—endogenous depression	5.18e-05	0.00179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—OXT—endogenous depression	5.14e-05	0.00177	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CRH—endogenous depression	5.14e-05	0.00177	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1A—endogenous depression	4.95e-05	0.0017	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—OXT—endogenous depression	4.67e-05	0.00161	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CRH—endogenous depression	4.67e-05	0.00161	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—COMT—endogenous depression	4.57e-05	0.00157	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOA—endogenous depression	4.54e-05	0.00156	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—POMC—endogenous depression	4.52e-05	0.00156	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	4.51e-05	0.00155	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1A—endogenous depression	4.49e-05	0.00155	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR7—endogenous depression	4.18e-05	0.00144	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—POMC—endogenous depression	4.14e-05	0.00143	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR7—endogenous depression	3.8e-05	0.00131	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WASF2—endogenous depression	3.6e-05	0.00124	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WASF1—endogenous depression	3.45e-05	0.00119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADM—endogenous depression	3.29e-05	0.00113	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—endogenous depression	2.95e-05	0.00102	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—endogenous depression	2.93e-05	0.00101	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TPH1—endogenous depression	2.76e-05	0.000952	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CRH—endogenous depression	2.76e-05	0.00095	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OXT—endogenous depression	2.76e-05	0.00095	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—endogenous depression	2.66e-05	0.000917	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1A—endogenous depression	2.65e-05	0.000914	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TPH1—endogenous depression	2.6e-05	0.000897	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—endogenous depression	2.34e-05	0.000806	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR7—endogenous depression	2.24e-05	0.000773	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—endogenous depression	2.12e-05	0.000732	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TPH2—endogenous depression	2.09e-05	0.000722	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNB2—endogenous depression	2.09e-05	0.000722	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DPYD—endogenous depression	2.06e-05	0.00071	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNB2—endogenous depression	1.97e-05	0.00068	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TPH2—endogenous depression	1.97e-05	0.00068	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DPYD—endogenous depression	1.94e-05	0.000669	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNA1C—endogenous depression	1.92e-05	0.00066	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNA1C—endogenous depression	1.8e-05	0.000622	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TPH1—endogenous depression	1.7e-05	0.000587	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2D6—endogenous depression	1.67e-05	0.000577	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—endogenous depression	1.57e-05	0.000542	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TPH2—endogenous depression	1.29e-05	0.000445	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNB2—endogenous depression	1.29e-05	0.000445	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DPYD—endogenous depression	1.27e-05	0.000437	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—COMT—endogenous depression	1.27e-05	0.000437	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOA—endogenous depression	1.26e-05	0.000434	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—endogenous depression	1.26e-05	0.000433	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—COMT—endogenous depression	1.2e-05	0.000412	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOA—endogenous depression	1.19e-05	0.000409	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.18e-05	0.000407	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.03e-05	0.000355	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—endogenous depression	8.2e-06	0.000283	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COMT—endogenous depression	7.82e-06	0.000269	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOA—endogenous depression	7.76e-06	0.000267	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—endogenous depression	7.73e-06	0.000266	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—endogenous depression	5.05e-06	0.000174	CbGpPWpGaD
